#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia beta Epilepsy with myoclonic-atonic seizures Anal cancer Paraganglion neoplasm Hereditary ataxia Ocular lymphoma Chronic graft versus host disease Enteritis Hypophosphatasia Round cell liposarcoma Cholangiosarcoma Hyperchylomicronaemia Juvenile idiopathic arthritis Restless legs syndrome Neoplasm malignant More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma Progressive supranuclear palsy – Life with Disease Haemophagocytic lymphohistiocytosis – Diagnostics Cystic fibrosis lung – Treatment Lymphatic malformation – Trials in Disease Synovial sarcoma – Diagnostics Friedreich’s ataxia – Diagnostics Fabry’s disease – Treatment Metachromatic leukodystrophy – Treatment Sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiotropium Agomelatine GXV813 Cpk850 Cabozantinib Cilgavimab Florbetaben (18F) Heterodimeric Interleukin-15 Hydroxocobalamin Posenacaftor Tabelecleucel Dcc-3116 Nimotuzumab Lasofoxifene Trimethoprim Iph5201 ABIRATERONE DECANOATE Mometasone Clioquinol Inotuzumab Ozogamicin More therapies…

    Learn about Your Condition

    Niemann-Pick disease Atrial septal defect Onychomycosis Renal cancer stage IV Osteosarcoma Periarthritis Clinically isolated syndrome Traumatic pain Growth hormone deficiency Varicella Arthritis infective Otitis media Takayasu's arteritis Ischaemic stroke Head and neck cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sickle cell disease

  • A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Crizanlizumab
    Belgium France Germany Italy Spain

  • Study on the Effectiveness of Decitabine and Tetrahydrouridine in Patients with Sickle Cell Disease Not Eligible for Hydroxyurea Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Tetrahydrouridine
    • Hydroxycarbamide
    • Decitabine
    France Greece Italy Spain

  • Study on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    France Germany Greece Italy Spain

  • Study on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell disease
    France Italy The Netherlands Spain

  • Study on the Safety and Effects of Crovalimab for Treating Vaso-Occlusive Episodes in Sickle Cell Disease Patients

    Not recruiting

    1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell disease
    Investigated Drugs:
    • Crovalimab
    France Italy The Netherlands Spain

  • Study on the Effect of Famotidine in Reducing P-selectin Levels in Children with Sickle Cell Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Famotidine
    France
Previous Page
1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!